TrialSignal transduction and targeted therapy2021

Antibody-dependent cellular cytotoxicity response to SARS-CoV-2 in COVID-19 patients.

Yuanling Yu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.